The FDA is issuing warning letters to 12 manufacturers of breast binders which are medical devices used for purposes such as assistance in recovery from cancer related mastectomies. The FDA is issuing warning letters to 12 manufacturers of breast binders... for the purpose of treating gender dysphoria commits significant regulatory violations. and requires swift congressional or corrective action. If the manufacturers don't comply, they could face enforcement actions including product seizures. (03:55–04:22)
CLAIM
Asserts that the FDA is warning manufacturers about regulatory violations related to breast binders.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
